- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 29, 2025 | 27.09M sh |
| Cash And Equivalents | Q2 2025 · Mar 29, 2025 | $310.53M |
| Cash And Equivalents | Q2 2025 · Sep 28, 2024 | $345.11M |
| Current Liabilities | Q2 2025 · Mar 29, 2025 | $1.57B |
| Current Liabilities | Q2 2025 · Sep 28, 2024 | $1.64B |
| Total Liabilities | Q2 2025 · Mar 29, 2025 | $1.73B |
| Total Liabilities | Q2 2025 · Sep 28, 2024 | $1.83B |
| Current Assets | Q2 2025 · Mar 29, 2025 | $2.4B |
| Current Assets | Q2 2025 · Sep 28, 2024 | $2.48B |
| Total Assets | Q2 2025 · Mar 29, 2025 | $3.09B |
| Total Assets | Q2 2025 · Sep 28, 2024 | $3.15B |
| Shares Diluted | Q2 2025 · Mar 30, 2024 | 27.93M sh |
| Shares Diluted | Q2 2025 · Mar 30, 2024 | 27.98M sh |
| Stock Repurchased | Q2 2025 · Mar 30, 2024 | $17.57M |
| Capex | Q2 2025 · Mar 30, 2024 | $51.52M |
| Operating Cash Flow | Q2 2025 · Mar 30, 2024 | $84.77M |
| Stockholders Equity | Q2 2025 · Mar 30, 2024 | $1.26B |
| Stockholders Equity | Q2 2025 · Dec 30, 2023 | $1.27B |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $1.21B |
| Eps Diluted | Q2 2025 · Mar 30, 2024 | $0.58 |
| Eps Diluted | Q2 2025 · Mar 30, 2024 | $1.62 |
| Eps Basic | Q2 2025 · Mar 30, 2024 | $0.59 |
| Eps Basic | Q2 2025 · Mar 30, 2024 | $1.65 |
| Sga Expense | Q2 2025 · Mar 30, 2024 | $47.56M |
| Sga Expense | Q2 2025 · Mar 30, 2024 | $90.54M |
| Net Income | Q2 2025 · Mar 30, 2024 | $16.24M |
| Net Income | Q2 2025 · Mar 30, 2024 | $45.45M |
| Operating Income | Q2 2025 · Mar 30, 2024 | $29.47M |
| Operating Income | Q2 2025 · Mar 30, 2024 | $74.63M |
| Gross Profit | Q2 2025 · Mar 30, 2024 | $88.06M |
| Gross Profit | Q2 2025 · Mar 30, 2024 | $176.2M |
| Cost Of Revenue | Q2 2025 · Mar 30, 2024 | $878.84M |
| Cost Of Revenue | Q2 2025 · Mar 30, 2024 | $1.77B |
| Revenue restated | Q2 2025 · Mar 30, 2024 | $966.9K |
| Revenue restated | Q2 2025 · Mar 30, 2024 | $1.95M |